AIM
LXRX icon

Ada Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Ada Investment Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$260K Buy
+19,545
New +$240K 0.18% 244

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Ada Investment Management's LXRX Position: Q4 2015 in Review

Ada Investment Management opened a new position in Lexicon Pharmaceuticals (LXRX) in Q4 2015: 19,545 shares worth $260K. The stake represents 0.18% of the portfolio and ranks #244 among its holdings.

118 funds tracked by Wall St. Rank hold LXRX as of Q4 2015.

  • Ada Investment Management held 19,545 shares of Lexicon Pharmaceuticals worth $260K as of Q4 2015.
  • Lexicon Pharmaceuticals was a new Ada Investment Management position in Q4 2015.
  • Lexicon Pharmaceuticals made up 0.18% of Ada Investment Management's portfolio in Q4 2015, its #244 holding.
  • 118 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.